Login Register Cart 0
Generic placeholder image

Current Drug Metabolism

Editor-in-Chief

ISSN (Print): 1389-2002
ISSN (Online): 1875-5453

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Secondary Metabolites as Treatment of Choice for Metabolic Disorders and Infectious Diseases and their Metabolic Profiling: Part 1

Author(s): Rajeev K. Singla

Volume 21, Issue 7, 2020

Page: [480 - 481] Pages: 2

DOI: 10.2174/138920022107200925101631

« Previous Next »
[1]
Golden, S.H.; Robinson, K.A.; Saldanha, I.; Anton, B.; Ladenson, P.W. Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J. Clin. Endocrinol. Metab., 2009, 94(6), 1853-1878.
[http://dx.doi.org/10.1210/jc.2008-2291]
[2]
Singla, R.K.; Dubey, A.K. Phytochemical profiling, GC-MS analysis, and α-amylase inhibitory potential of ethanolic extract of Cocos nucifera Linn. endocarp. Endocr. Metab. Immune Disord. Drug Targets, 2019, 19(4), 419-442.
[http://dx.doi.org/10.2174/1871530319666181128100206]
[3]
Scotti, L.; Monteiro, A.F.M.; de Oliveira Viana, J.; Mendonca Junior, F.J.B.; Ishiki, H.M.; Tchouboun, E.N.; Santos, R.; Scotti, M.T. Multi-target drugs against metabolic disorders. Endocr. Metab. Immune Disord. Drug Targets, 2019, 19(4), 402-418.
[http://dx.doi.org/10.2174/1871530319666181217123357]
[4]
Melaku, Y.A.; Wassie, M.M.; Gill, T.K.; Zhou, S.J.; Tessema, G.A.; Amare, A.T.; Lakew, Y.; Hiruye, A.; Bekele, T.H.; Worku, A.; Seid, O.; Endris, K.; Lemma, F.; Tesfay, F.H.; Yirsaw, B.D.; Deribe, K.; Adams, R.; Shi, Z.; Misganaw, A.; Deribew, A. Burden of disease attributable to suboptimal diet, metabolic risks and low physical activity in Ethiopia and comparison with Eastern sub-Saharan African countries, 1990-2015: findings from the Global Burden of Disease Study 2015. BMC Public Health, 2018, 18(1), 552.
[http://dx.doi.org/10.1186/s12889-018-5438-1]
[5]
Aliev, G.; Cacabelos, R.; Reddy, V.P. Metabolic disorders, drug development, drug design and biomarkers. Curr. Pharm. Des., 2016, 22(7), 765-767.
[http://dx.doi.org/10.2174/138161282207160127173155]
[6]
El-Deeb, W.M.; Elmoslemany, A.M. Cardiac and oxidative stress biomarkers in Trypanosoma evansi infected camels: diagnostic and prognostic prominence. Parasitology, 2015, 142(6), 767-772.
[http://dx.doi.org/10.1017/S0031182014001899]
[7]
De, B.; Bhandari, K.; Singla, R.K.; Saha, G.; Goswami, T.K. In silico molecular GRIP docking of some secondary metabolites combating diabesity. Bull. Natl. Res. Cent., 2020, 44, 66.
[http://dx.doi.org/10.1186/s42269-020-00327-7]
[8]
Pappachan, J.M.; Fernandez, C.J.; Chacko, E.C. Diabesity and antidiabetic drugs. Mol. Aspects Med., 2019, 66, 3-12.
[http://dx.doi.org/10.1016/j.mam.2018.10.004]
[9]
Kasote, D.M.; Jagtap, S.D.; Thapa, D.; Khyade, M.S.; Russell, W.R. Herbal remedies for urinary stones used in India and China: A review. J. Ethnopharmacol., 2017, 203, 55-68.
[http://dx.doi.org/10.1016/j.jep.2017.03.038]
[10]
Chauhan, D.S.; Gupta, P.; Pottoo, F.H.; Amir, M. Secondary metabolites in the treatment of diabetes mellitus: a paradigm shift. Curr. Drug Metabol., 2020, 21
[http://dx.doi.org/10.2174/1389200221666200514081947]
[11]
Magani, S.K.J.; Mupparthi, S.D.; Gollapalli, B.P.; Shukla, D.; Tiwari, A.K.; Gorantala, J.; Yarla, N.S.; Tantravahi, S. Salidroside - Can it be a multifunctional drug? Curr. Drug Metabol., 2020, 21
[http://dx.doi.org/10.2174/1389200221666200610172105]
[12]
Lorenzo, V.P.; Scotti, L.; Almeida, J.R.G.S.; Scotti, M.T. Annonaceae family alkaloids as agents against leishmaniasis: review and molecular docking evaluation. Curr. Drug Metabol., 2020, 21
[http://dx.doi.org/10.2174/1389200221666200702124046]
[13]
Chaubey, A.; Dubey, A.K. Chemistry and antioxidant potential of phytoconstituents from Aegle marmelos fruit-shell. Curr. Drug Metabol., 2020, 21
[http://dx.doi.org/10.2174/1389200221666200711161056]

Rights & Permissions Print Cite
Article Metrics
5
© 2024 Bentham Science Publishers | Privacy Policy